CoChat
Sign Up
Cited by 870

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Exosomes in cancer development, metastasis, and immunity

Zhang, Lin, Yu, Dihua·2019·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
DOI 10.1016/j.bbcan.2019.04.004PMC PMC6542596
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbcan.2019.04.004

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 157

  1. Pan, 1985, Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes, J. Cell Biol., 101, 942, 10.1083/jcb.101.3.942 · DOI
  2. Harding, 1983, Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes, J. Cell Biol., 97, 329, 10.1083/jcb.97.2.329 · DOI · Paper page
  3. Thery, 2009, Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol., 9, 581, 10.1038/nri2567 · DOI
  4. Bobrie, 2012, Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation, J. Extracell. Vesicles, 1, 10.3402/jev.v1i0.18397 · DOI
  5. Zhang, 2018, Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation, Nat. Cell Biol., 20, 332, 10.1038/s41556-018-0040-4 · DOI
  6. Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol., 30, 255, 10.1146/annurev-cellbio-101512-122326 · DOI · Paper page
  7. Heijnen, 1999, Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules, Blood, 94, 3791, 10.1182/blood.V94.11.3791 · DOI
  8. van der Pol, 2012, Classification, functions, and clinical relevance of extracellular vesicles, Pharmacol. Rev., 64, 676, 10.1124/pr.112.005983 · DOI
  9. Gasser, 2003, Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils, Exp. Cell Res., 285, 243, 10.1016/S0014-4827(03)00055-7 · DOI
  10. Ronquist, 1977, Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A, Biochim. Biophys. Acta, 483, 483, 10.1016/0005-2744(77)90078-X · DOI
  11. Ronquist, 1978, An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic fluid–part II, Andrologia, 10, 427, 10.1111/j.1439-0272.1978.tb03064.x · DOI
  12. Ma, 2015, Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration, Cell Res., 25, 24, 10.1038/cr.2014.135 · DOI
  13. Al-Nedawi, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat. Cell Biol., 10, 619, 10.1038/ncb1725 · DOI
  14. Meehan, 2016, Oncosomes - large and small: what are they, where they came from?, J. Extracell. Vesicles, 5, 10.3402/jev.v5.33109 · DOI
  15. Konoshenko, 2018, Isolation of extracellular vesicles: general methodologies and latest trends, Biomed. Res. Int., 2018, 10.1155/2018/8545347 · DOI
  16. Di Vizio, 2009, Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease, Cancer Res., 69, 5601, 10.1158/0008-5472.CAN-08-3860 · DOI
  17. Xu, 2018, Extracellular vesicles in cancer - implications for future improvements in cancer care, Nat. Rev. Clin. Oncol., 15, 617, 10.1038/s41571-018-0036-9 · DOI
  18. Henne, 2013, Molecular mechanisms of the membrane sculpting ESCRT pathway, Cold Spring Harb. Perspect. Biol., 5, 10.1101/cshperspect.a016766 · DOI
  19. Katzmann, 2001, Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I, Cell, 106, 145, 10.1016/S0092-8674(01)00434-2 · DOI
  20. Hanson, 2012, Multivesicular body morphogenesis, Annu. Rev. Cell Dev. Biol., 28, 337, 10.1146/annurev-cellbio-092910-154152 · DOI
  21. Trajkovic, 2008, Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, 319, 1244, 10.1126/science.1153124 · DOI
  22. Ghossoub, 2014, Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2, Nat. Commun., 5, 3477, 10.1038/ncomms4477 · DOI
  23. Babst, 2011, MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between, Curr. Opin. Cell Biol., 23, 452, 10.1016/j.ceb.2011.04.008 · DOI
  24. van Niel, 2011, The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis, Dev. Cell, 21, 708, 10.1016/j.devcel.2011.08.019 · DOI · Paper page
  25. Ostrowski, 2010, Rab27a and Rab27b control different steps of the exosome secretion pathway, Nat. Cell Biol., 12, 19, 10.1038/ncb2000 · DOI
  26. Hsu, 2010, Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C, J. Cell Biol., 189, 223, 10.1083/jcb.200911018 · DOI
  27. Gu, 2016, Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis, J. Clin. Invest., 126, 4537, 10.1172/JCI87105 · DOI
  28. Zylbersztejn, 2011, Vesicular traffic in cell navigation, FEBS J., 278, 4497, 10.1111/j.1742-4658.2011.08168.x · DOI
  29. Fader, 2009, TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways, Biochim. Biophys. Acta, 1793, 1901, 10.1016/j.bbamcr.2009.09.011 · DOI
  30. Parolini, 2009, Microenvironmental pH is a key factor for exosome traffic in tumor cells, J. Biol. Chem., 284, 34211, 10.1074/jbc.M109.041152 · DOI
  31. Muralidharan-Chari, 2009, ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles, Curr. Biol., 19, 1875, 10.1016/j.cub.2009.09.059 · DOI · Paper page
  32. Li, 2012, RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells, Oncogene, 31, 4740, 10.1038/onc.2011.636 · DOI
  33. Muhsin-Sharafaldine, 2018, Tumor-derived apoptotic vesicles: with death they do part, Front. Immunol., 9, 957, 10.3389/fimmu.2018.00957 · DOI
  34. Kowal, 2014, Biogenesis and secretion of exosomes, Curr. Opin. Cell Biol., 29, 116, 10.1016/j.ceb.2014.05.004 · DOI · Paper page
  35. Munson, 2015, Exosomes: Potential in Cancer Diagnosis and Therapy, Medicines (Basel), 2, 310
  36. Zitvogel, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat. Med., 4, 594, 10.1038/nm0598-594 · DOI
  37. Zhang, 2015, Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth, Nature, 527, 100, 10.1038/nature15376 · DOI · Paper page
  38. Thakur, 2014, Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res., 24, 766, 10.1038/cr.2014.44 · DOI
  39. Zhao, 2016, Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism, Elife, 5, 10.7554/eLife.10250 · DOI · Paper page
  40. Mathivanan, 2012, ExoCarta 2012: database of exosomal proteins, RNA and lipids, Nucleic Acids Res., 40, D1241, 10.1093/nar/gkr828 · DOI
  41. Batagov, 2011, Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles, BMC Genomics, 12, S18, 10.1186/1471-2164-12-S3-S18 · DOI
  42. Cha, 2015, KRAS-dependent sorting of miRNA to exosomes, Elife, 4, 10.7554/eLife.07197 · DOI
  43. Rana, 2012, Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection, Int. J. Biochem. Cell Biol., 44, 1574, 10.1016/j.biocel.2012.06.018 · DOI
  44. Nazarenko, 2010, Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation, Cancer Res., 70, 1668, 10.1158/0008-5472.CAN-09-2470 · DOI
  45. Zomer, 2015, In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior, Cell, 161, 1046, 10.1016/j.cell.2015.04.042 · DOI
  46. Raimondo, 2015, Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism, Cell Commun. Sign. CCS, 13, 8, 10.1186/s12964-015-0086-x · DOI
  47. Kalluri, 2016, Discovery of double-stranded genomic DNA in circulating exosomes, Cold Spring Harb. Symp. Quant. Biol., 81, 275, 10.1101/sqb.2016.81.030932 · DOI
  48. Demory Beckler, 2013, Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS, Mol. Cell. Proteomics, 12, 343, 10.1074/mcp.M112.022806 · DOI
  49. Yang, 2018, Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth, Cell Res., 28, 862, 10.1038/s41422-018-0060-4 · DOI
  50. Pavlyukov, 2018, Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing factors, Cancer Cell, 34, 119, 10.1016/j.ccell.2018.05.012 · DOI
  51. Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 · DOI · Paper page
  52. Antonyak, 2011, Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells, Proc. Natl. Acad. Sci. U. S. A., 108, 4852, 10.1073/pnas.1017667108 · DOI
  53. Cho, 2012, Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells, Int. J. Oncol., 40, 130
  54. Webber, 2010, Cancer exosomes trigger fibroblast to myofibroblast differentiation, Cancer Res., 70, 9621, 10.1158/0008-5472.CAN-10-1722 · DOI
  55. Gesierich, 2006, Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029, Cancer Res., 66, 7083, 10.1158/0008-5472.CAN-06-0391 · DOI
  56. Sheldon, 2010, New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes, Blood, 116, 2385, 10.1182/blood-2009-08-239228 · DOI
  57. Tang, 2018, Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface, Nat. Commun., 9, 2270, 10.1038/s41467-018-04695-7 · DOI
  58. Svensson, 2011, Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells, Proc. Natl. Acad. Sci. U. S. A., 108, 13147, 10.1073/pnas.1104261108 · DOI · Paper page
  59. Hsu, 2017, Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1, Oncogene, 36, 4929, 10.1038/onc.2017.105 · DOI
  60. Nabet, 2017, Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer, Cell, 170, 352, 10.1016/j.cell.2017.06.031 · DOI
  61. Shimoda, 2014, Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state, Nat. Cell Biol., 16, 889, 10.1038/ncb3021 · DOI
  62. Achreja, 2017, Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism, Metab. Eng., 43 (, 156, 10.1016/j.ymben.2017.01.001 · DOI
  63. Luciani, 2004, Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs, J. Natl. Cancer Inst., 96, 1702, 10.1093/jnci/djh305 · DOI · Paper page
  64. Chen, 2006, Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas, Proc. Natl. Acad. Sci. U. S. A., 103, 9903, 10.1073/pnas.0600213103 · DOI
  65. Safaei, 2005, Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells, Mol. Cancer Ther., 4, 1595, 10.1158/1535-7163.MCT-05-0102 · DOI
  66. Yin, 2012, Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients, J. Cell. Mol. Med., 16, 337, 10.1111/j.1582-4934.2011.01316.x · DOI
  67. Bebawy, 2009, Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells, Leukemia, 23, 1643, 10.1038/leu.2009.76 · DOI
  68. Chen, 2014, Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs, PLoS ONE, 9
  69. Qin, 2017, Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner, Int. J. Nanomedicine, 12, 3721, 10.2147/IJN.S131516 · DOI
  70. Yang, 2017, Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer, Gene, 623, 5, 10.1016/j.gene.2017.04.031 · DOI
  71. Qu, 2016, Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA, Cancer Cell, 29, 653, 10.1016/j.ccell.2016.03.004 · DOI
  72. Martinez, 2017, Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles, Oncoimmunology, 6, 10.1080/2162402X.2017.1362530 · DOI
  73. Boelens, 2014, Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways, Cell, 159, 499, 10.1016/j.cell.2014.09.051 · DOI
  74. Binenbaum, 2018, Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma, Cancer Res., 78, 5287, 10.1158/0008-5472.CAN-18-0124 · DOI
  75. Namee, 2018, Extracellular vesicles and anti-cancer drug resistance, Biochim. Biophys. Acta Rev. Cancer, 1870, 123, 10.1016/j.bbcan.2018.07.003 · DOI
  76. Sung, 2015, Directional cell movement through tissues is controlled by exosome secretion, Nat. Commun., 6, 7164, 10.1038/ncomms8164 · DOI
  77. Yue, 2015, The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding, Oncotarget, 2366, 10.18632/oncotarget.2958 · DOI
  78. Hendrix, 2010, Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis, J. Natl. Cancer Inst., 102, 866, 10.1093/jnci/djq153 · DOI
  79. Aga, 2014, Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes, Oncogene, 33, 4613, 10.1038/onc.2014.66 · DOI
  80. You, 2015, Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis, Cancer Sci., 106, 1669, 10.1111/cas.12818 · DOI
  81. Jeppesen, 2014, Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors, Proteomics, 14, 699, 10.1002/pmic.201300452 · DOI
  82. Yoshizaki, 2013, Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma, Cancer Lett., 337, 1, 10.1016/j.canlet.2013.05.018 · DOI
  83. Ostenfeld, 2014, Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties, Cancer Res., 74, 5758, 10.1158/0008-5472.CAN-13-3512 · DOI
  84. Tominaga, 2015, Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier, Nat. Commun., 6, 6716, 10.1038/ncomms7716 · DOI · Paper page
  85. Hood, 2011, Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis, Cancer Res., 71, 3792, 10.1158/0008-5472.CAN-10-4455 · DOI
  86. Rana, 2013, Exosomal tumor microRNA modulates premetastatic organ cells, Neoplasia, 15, 281, 10.1593/neo.122010 · DOI
  87. Karlsson, 2016, Tumor cell-derived exosomes from the prostate cancer cell line TRAMP-C1 impair osteoclast formation and differentiation, PLoS ONE, 11, 10.1371/journal.pone.0166284 · DOI
  88. Ye, 2017, Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer, Oncotarget, 8, 94834, 10.18632/oncotarget.22014 · DOI
  89. Jung, 2009, CD44v6 dependence of premetastatic niche preparation by exosomes, Neoplasia, 11, 1093, 10.1593/neo.09822 · DOI
  90. Grange, 2011, Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche, Cancer Res., 71, 5346, 10.1158/0008-5472.CAN-11-0241 · DOI
  91. Peinado, 2012, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET, Nat. Med., 18, 883, 10.1038/nm.2753 · DOI · Paper page
  92. Liu, 2016, Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils, Cancer Cell, 30, 243, 10.1016/j.ccell.2016.06.021 · DOI
  93. Plebanek, 2017, Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche, Nat. Commun., 8, 1319, 10.1038/s41467-017-01433-3 · DOI
  94. Valencia, 2014, miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization, Mol. Oncol., 8, 689, 10.1016/j.molonc.2014.01.012 · DOI
  95. Ono, 2014, Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells, Sci. Signal., 7, ra63, 10.1126/scisignal.2005231 · DOI
  96. Wolfers, 2001, Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat. Med., 7, 297, 10.1038/85438 · DOI
  97. Dai, 2005, More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells, Clin. Cancer Res. Offi. J. Am. Asso. Cancer Res., 11, 7554, 10.1158/1078-0432.CCR-05-0810 · DOI
  98. Dai, 2006, Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells, J. Mol. Med., 84, 1067, 10.1007/s00109-006-0102-0 · DOI
  99. Zhang, 2012, Exosomes and immune surveillance of neoplastic lesions: a review, Biotech. Histochem. Offi. Publ. Biol. Stain Comm., 87, 161, 10.3109/10520291003659042 · DOI
  100. Filipazzi, 2012, Recent advances on the role of tumor exosomes in immunosuppression and disease progression, Semin. Cancer Biol., 22, 342, 10.1016/j.semcancer.2012.02.005 · DOI
  101. Altieri, 2004, Exosomes from plasmacytoma cells as a tumor vaccine, J. Immunother., 27, 282, 10.1097/00002371-200407000-00004 · DOI
  102. Gastpar, 2005, Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells, Cancer Res., 65, 5238, 10.1158/0008-5472.CAN-04-3804 · DOI
  103. Vega, 2008, Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages, J. Immunol., 180, 4299, 10.4049/jimmunol.180.6.4299 · DOI
  104. Cho, 2009, MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models, Cancer Lett., 275, 256, 10.1016/j.canlet.2008.10.021 · DOI
  105. Li, 2013, Exosomes derived from Rab27aoverexpressing tumor cells elicit efficient induction of antitumor immunity, Mol. Med. Rep., 8, 1876, 10.3892/mmr.2013.1738 · DOI
  106. Andre, 2002, Malignant effusions and immunogenic tumour-derived exosomes, Lancet, 360, 295, 10.1016/S0140-6736(02)09552-1 · DOI
  107. Moroishi, 2016, The hippo pathway kinases LATS1/2 suppress cancer immunity, Cell, 167, 1525, 10.1016/j.cell.2016.11.005 · DOI
  108. Kitai, 2017, DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity, J. Immunol., 198, 1649, 10.4049/jimmunol.1601694 · DOI
  109. Muhsin-Sharafaldine, 2016, Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles, Oncotarget, 7, 56279, 10.18632/oncotarget.10783 · DOI
  110. Bobrie, 2011, Exosome secretion: molecular mechanisms and roles in immune responses, Traffic, 12, 1659, 10.1111/j.1600-0854.2011.01225.x · DOI
  111. Lundholm, 2014, Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion, PLoS ONE, 9, 10.1371/journal.pone.0108925 · DOI
  112. Clayton, 2008, Human tumor-derived exosomes down-modulate NKG2D expression, J. Immunol., 180, 7249, 10.4049/jimmunol.180.11.7249 · DOI
  113. Iero, 2008, Tumour-released exosomes and their implications in cancer immunity, Cell Death Differ., 15, 80, 10.1038/sj.cdd.4402237 · DOI
  114. Abusamra, 2005, Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis, Blood Cells Mol. Dis., 35, 169, 10.1016/j.bcmd.2005.07.001 · DOI
  115. Klibi, 2009, Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells, Blood, 113, 1957, 10.1182/blood-2008-02-142596 · DOI
  116. Soderberg, 2007, Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes, Free Radic. Biol. Med., 43, 90, 10.1016/j.freeradbiomed.2007.03.026 · DOI
  117. Clayton, 2007, Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2, Cancer Res., 67, 7458, 10.1158/0008-5472.CAN-06-3456 · DOI
  118. Chen, 2018, Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response, Nature, 560, 382, 10.1038/s41586-018-0392-8 · DOI · Paper page
  119. Zhou, 2014, Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203, Cell. Immunol., 292, 65, 10.1016/j.cellimm.2014.09.004 · DOI
  120. Ning, 2018, Tumor exosomes block dendritic cells maturation to decrease the T cell immune response, Immunol. Lett., 199, 36, 10.1016/j.imlet.2018.05.002 · DOI
  121. Xiang, 2009, Induction of myeloid-derived suppressor cells by tumor exosomes, Int. J. Cancer, 124, 2621, 10.1002/ijc.24249 · DOI
  122. Liu, 2010, Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells, Am. J. Pathol., 176, 2490, 10.2353/ajpath.2010.090777 · DOI
  123. Chalmin, 2010, Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J. Clin. Invest., 120, 457
  124. Diao, 2015, Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3, Med. Oncol., 32, 453, 10.1007/s12032-014-0453-2 · DOI
  125. Ridder, 2015, Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment, Oncoimmunology, 4, 10.1080/2162402X.2015.1008371 · DOI
  126. Guo, 2018, Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways, Oncogene, 37, 4239, 10.1038/s41388-018-0261-9 · DOI
  127. Ham, 2018, Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling, Front. Immunol., 9, 871, 10.3389/fimmu.2018.00871 · DOI
  128. Hsieh, 2018, Snail-overexpressing cancer cells promote M2-like polarization of tumor-associated macrophages by delivering MiR-21-abundant exosomes, Neoplasia, 20, 775, 10.1016/j.neo.2018.06.004 · DOI
  129. Wang, 2018, Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis, Cancer Res., 78, 4586, 10.1158/0008-5472.CAN-17-3841 · DOI
  130. Cooks, 2018, Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246, Nat. Commun., 9, 771, 10.1038/s41467-018-03224-w · DOI
  131. Gao, 2018, Tumor-derived exosomes antagonize innate antiviral immunity, Nat. Immunol., 19, 233, 10.1038/s41590-017-0043-5 · DOI
  132. Wang, 2018, Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression, Oncogenesis, 7, 41, 10.1038/s41389-018-0049-3 · DOI
  133. Gabrusiewicz, 2018, Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes, Oncoimmunology, 7, 10.1080/2162402X.2017.1412909 · DOI
  134. Xiao, 2018, M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma, J. Exp. Clin. Cancer Res., 37, 143, 10.1186/s13046-018-0815-2 · DOI
  135. Marton, 2012, Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro, Immunol. Lett., 148, 34, 10.1016/j.imlet.2012.07.006 · DOI
  136. Chow, 2014, Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kappaB, Sci. Rep., 4, 5750, 10.1038/srep05750 · DOI
  137. Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
  138. Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  139. Wang, 2013, Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids, Nat. Commun., 4, 1867, 10.1038/ncomms2886 · DOI
  140. Bourderioux, 2015, A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients, J. Proteome Res., 14, 567, 10.1021/pr501003q · DOI
  141. Morse, 2005, A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med., 3, 9, 10.1186/1479-5876-3-9 · DOI
  142. Dai, 2008, Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, Mol. Ther., 16, 782, 10.1038/mt.2008.1 · DOI
  143. Escudier, 2005, Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial, J. Transl. Med., 3, 10, 10.1186/1479-5876-3-10 · DOI
  144. Besse, 2016, Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC, Oncoimmunology, 5, 10.1080/2162402X.2015.1071008 · DOI · Paper page
  145. Marleau, 2012, Exosome removal as a therapeutic adjuvant in cancer, J. Transl. Med., 10, 134, 10.1186/1479-5876-10-134 · DOI
  146. Datta, 2018, High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer, Sci. Rep., 8, 8161, 10.1038/s41598-018-26411-7 · DOI
  147. Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper, J. Extracell. Vesicles, 4, 10.3402/jev.v4.30087 · DOI · Paper page
  148. Theodoraki, 2018, Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients, Clin. Cancer Res., 24, 896, 10.1158/1078-0432.CCR-17-2664 · DOI · Paper page
  149. Ludwig, 2017, Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer, Clin. Cancer Res., 23, 4843, 10.1158/1078-0432.CCR-16-2819 · DOI
  150. An, 2017, Quantitative proteomic analysis of serum exosomes from patients with locally advanced pancreatic cancer undergoing chemoradiotherapy, J. Proteome Res., 16, 1763, 10.1021/acs.jproteome.7b00024 · DOI
  151. Becker, 2016, Extracellular vesicles in cancer: Cell-to-Cell mediators of metastasis, Cancer Cell, 30, 836, 10.1016/j.ccell.2016.10.009 · DOI · Paper page
  152. Goto, 2018, An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker, BMC Cancer, 18, 116, 10.1186/s12885-018-4006-5 · DOI
  153. Akers, 2013, MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development, PLoS ONE, 8, 10.1371/journal.pone.0078115 · DOI
  154. Shi, 2015, Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients, Oncotarget, 6, 26971, 10.18632/oncotarget.4699 · DOI
  155. Fu, 2018, Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer, Transl. Oncol., 11, 221, 10.1016/j.tranon.2017.12.012 · DOI
  156. Lai, 2017, A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer, Cancer Lett., 393, 86, 10.1016/j.canlet.2017.02.019 · DOI
  157. McKiernan, 2016, A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy, JAMA Oncol, 2, 882, 10.1001/jamaoncol.2016.0097 · DOI

Cited by

Sorted by citations

See all 870

Metadata

Authors
Zhang, L., & Yu, D.
Venue
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Publisher
Elsevier BV
Published
2019-04
Volume
1871
Issue
2
Pages
455-468
ISSN
0304-419X
DOI
10.1016/j.bbcan.2019.04.004
PMC
PMC6542596
Cited by
870
References
20
Language
en
Licence
Funders
National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review